Epigenetic regulation and the pathogenesis of systemic lupus erythematosus

被引:77
|
作者
Pan, Yujun
Sawalha, Amr H.
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Arthrit & Immunol Program,Dept Med, Oklahoma City, OK USA
[2] US Dept Vet Affairs, Med Ctr, Oklahoma City, OK USA
基金
新加坡国家研究基金会;
关键词
DRUG-INDUCED LUPUS; CD4(+) T-CELLS; DNA METHYLATION INHIBITORS; MRL-LPR/LPR MOUSE; GENE-EXPRESSION; IN-VITRO; HISTONE MODIFICATIONS; AUTOIMMUNE-DISEASE; SYNGENEIC MICE; RENAL-DISEASE;
D O I
10.1016/j.trsl.2008.10.007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The pathogenesis of systemic lupus erythematosus (SLE) is incompletely understood. Studies in both lupus animal models and human disease indicate a clear role for epigenetic defects, particularly DNA methylation, in the pathogenesis of lupus. T-cell DNA from active lupus patients is hypomethylated, which results in overexpression of methylation-regulated genes, T-cell autoreactivity, and autoimmunity in vivo. Inducing an extracellular signal-regulated kinase (ERK) signaling defect in T cells using a transgenic mouse model resulted in reduced DNA methyltransferase 1 (DNMT1) expression, overexpression of methylation-sensitive genes, and anti-double-stranded DNA (anti-dsDNA) antibody production. ERK signaling is known to be defective in lupus T cells, and this defect is now explained by impaired T-cell protein kinase C (PKC) delta activation. Herein, we discuss how defective epigenetic regulation is involved in the pathogenesis of lupus, which includes both DNA methylation and histone modification changes. (Translational Research 2009;153:4-10)
引用
收藏
页码:4 / 10
页数:7
相关论文
共 50 条
  • [31] Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus
    Qing, XP
    Putterman, C
    AUTOIMMUNITY REVIEWS, 2004, 3 (7-8) : 505 - 509
  • [32] The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus
    Goropevsek, Ales
    Holcar, Marija
    Avcin, Tadej
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 52 (02) : 164 - 181
  • [33] MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis
    Shen, Nan
    Liang, Dong
    Tang, YuanJia
    de Vries, Niek
    Tak, Paul-Peter
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (12) : 701 - 709
  • [34] Interferons in Systemic Lupus Erythematosus
    Sirobhushanam, Sirisha
    Lazar, Stephanie
    Kahlenberg, J. Michelle
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2021, 47 (03) : 297 - 315
  • [35] Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus
    Wu, Haijing
    Fu, Siqi
    Zhao, Ming
    Lu, Liwei
    Lu, Qianjin
    MOLECULES, 2017, 22 (01):
  • [36] Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis
    Belot, Alexandre
    Cimaz, Rolando
    PEDIATRIC RHEUMATOLOGY, 2012, 10
  • [37] Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine
    Lee, Iris
    Zickuhr, Lisa
    Hassman, Lynn
    CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (06) : 583 - 589
  • [38] Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus
    Means, TK
    Luster, AD
    HUMAN IMMUNOLOGY: PATIENT-BASED RESEARCH, 2005, 1062 : 242 - 251
  • [39] Systemic lupus erythematosus
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2016, 55 (560): : 45 - 47
  • [40] Cellular therapy of systemic lupus erythematosus
    Tyndall, A.
    LUPUS, 2009, 18 (05) : 387 - 393